FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017209924> ?p ?o ?g. }

• W2017209924 endingPage "440" @default.
• W2017209924 startingPage "434" @default.
• W2017209924 abstract "While responsive to androgen ablation in its early stages, prostate cancer eventually becomes castration-resistant and metastasizes preferentially to bone. Once this happens, the disease carries considerable morbidity and is incurable. The process of bone metastasis involves a complex interplay between tumour and bone tissue. The eventual characteristic clinical presentation of disorganized osteoblastic bone lesions is preceded by a facilitatory osteoblastic phase; an osteoblastic component then continues to underlie the process. Increasing evidence has shown a ubiquitous role for Src (a proto-oncogene tyrosine-protein kinase) in multiple tumour and bone-signalling processes involved in prostate tumour progression, driving proliferation, survival, migration and transition to androgen-independent growth. It is also intimately involved in positively regulating osteoclast physiology. As such, this molecule represents an attractive target for managing progressing prostate cancer. Encouraging results have been obtained in preclinical and clinical studies using Src inhibitors like AZD0530 and dasatinib. Both compounds reduced markers of bone resorption, in patients with cancer and those with advanced castration-resistant prostate cancer, respectively. Moreover, because Src is central to many mechanisms thought to be responsible for the development of castration resistance, adding Src inhibitors to a treatment regimen might reverse this phenomenon. As a result, many Src inhibitors are in preclinical development. This review explores Src inhibition as a strategy for managing bone metastasis in prostate cancer, with a particular focus on targeting the critical osteoclastic response. Other emerging and novel approaches are also considered." @default.
• W2017209924 created "2016-06-24" @default.
• W2017209924 creator A5053749991 @default.
• W2017209924 date "2009-02-01" @default.
• W2017209924 modified "2023-10-17" @default.
• W2017209924 title "Src as a therapeutic target in men with prostate cancer and bone metastases" @default.
• W2017209924 cites W1835497562 @default.
• W2017209924 cites W1972744500 @default.
• W2017209924 cites W1975120553 @default.
• W2017209924 cites W1976329877 @default.
• W2017209924 cites W1981232380 @default.
• W2017209924 cites W1983225862 @default.
• W2017209924 cites W1987126685 @default.
• W2017209924 cites W1988698591 @default.
• W2017209924 cites W1991541715 @default.
• W2017209924 cites W2000170431 @default.
• W2017209924 cites W2003973314 @default.
• W2017209924 cites W2011017763 @default.
• W2017209924 cites W2011926580 @default.
• W2017209924 cites W2023038458 @default.
• W2017209924 cites W2028135614 @default.
• W2017209924 cites W2028638661 @default.
• W2017209924 cites W2033526561 @default.
• W2017209924 cites W2036742255 @default.
• W2017209924 cites W2042692879 @default.
• W2017209924 cites W2043103956 @default.
• W2017209924 cites W2043933052 @default.
• W2017209924 cites W2047757959 @default.
• W2017209924 cites W2049953991 @default.
• W2017209924 cites W2051487479 @default.
• W2017209924 cites W2055489437 @default.
• W2017209924 cites W2060719489 @default.
• W2017209924 cites W2061921618 @default.
• W2017209924 cites W2062032920 @default.
• W2017209924 cites W2072119701 @default.
• W2017209924 cites W2074018758 @default.
• W2017209924 cites W2076675819 @default.
• W2017209924 cites W2076974856 @default.
• W2017209924 cites W2093395043 @default.
• W2017209924 cites W2098095736 @default.
• W2017209924 cites W2102352213 @default.
• W2017209924 cites W2104923745 @default.
• W2017209924 cites W2106712353 @default.
• W2017209924 cites W2111631361 @default.
• W2017209924 cites W2115510180 @default.
• W2017209924 cites W2117638862 @default.
• W2017209924 cites W2121263780 @default.
• W2017209924 cites W2123640548 @default.
• W2017209924 cites W2125528459 @default.
• W2017209924 cites W2126062646 @default.
• W2017209924 cites W2132484381 @default.
• W2017209924 cites W2134965738 @default.
• W2017209924 cites W2137881146 @default.
• W2017209924 cites W2142728728 @default.
• W2017209924 cites W2149612004 @default.
• W2017209924 cites W2156764315 @default.
• W2017209924 cites W2157820793 @default.
• W2017209924 cites W2158878352 @default.
• W2017209924 cites W2167331614 @default.
• W2017209924 cites W2172023530 @default.
• W2017209924 cites W2242850217 @default.
• W2017209924 cites W2282037799 @default.
• W2017209924 cites W2287514711 @default.
• W2017209924 cites W2300447981 @default.
• W2017209924 cites W2318160598 @default.
• W2017209924 cites W2323550971 @default.
• W2017209924 doi "https://doi.org/10.1111/j.1464-410x.2008.08249.x" @default.
• W2017209924 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19154462" @default.
• W2017209924 hasPublicationYear "2009" @default.
• W2017209924 type Work @default.
• W2017209924 sameAs 2017209924 @default.
• W2017209924 citedByCount "51" @default.
• W2017209924 countsByYear W20172099242012 @default.
• W2017209924 countsByYear W20172099242013 @default.
• W2017209924 countsByYear W20172099242014 @default.
• W2017209924 countsByYear W20172099242015 @default.
• W2017209924 countsByYear W20172099242016 @default.
• W2017209924 countsByYear W20172099242017 @default.
• W2017209924 countsByYear W20172099242019 @default.
• W2017209924 countsByYear W20172099242020 @default.
• W2017209924 countsByYear W20172099242022 @default.
• W2017209924 crossrefType "journal-article" @default.
• W2017209924 hasAuthorship W2017209924A5053749991 @default.
• W2017209924 hasConcept C108636557 @default.
• W2017209924 hasConcept C121608353 @default.
• W2017209924 hasConcept C126322002 @default.
• W2017209924 hasConcept C143998085 @default.
• W2017209924 hasConcept C170493617 @default.
• W2017209924 hasConcept C2776033226 @default.
• W2017209924 hasConcept C2776235491 @default.
• W2017209924 hasConcept C2777783956 @default.
• W2017209924 hasConcept C2779013556 @default.
• W2017209924 hasConcept C2779536868 @default.
• W2017209924 hasConcept C2780192828 @default.
• W2017209924 hasConcept C42362537 @default.
• W2017209924 hasConcept C502942594 @default.
• W2017209924 hasConcept C673006 @default.
• W2017209924 hasConcept C71924100 @default.

• next